Chang Z L, Lin M Q, Wang M Z, Yao Z
Shanghai Joint Laboratory of Life Sciences, Institute of Cell Biology, Chinese Academy of Sciences.
Shi Yan Sheng Wu Xue Bao. 1997 Mar;30(1):73-81.
Monocytes-macrophages which serve as host immune cells to kill pathogens can often be "activated" after exposing to viruses, bacteria, cytokines as well as chemical substances, However, it is paradoxical that highly activated macrophages can be induced to become the suppressor ones by live microbes, microbial products, tumor, and autoimmune disease, although the mechanism remains unknown. Our previous experimental studies have shown that immuno-suppressor activities of suppressor macrophages on T, B and NK cells can be prevented by the treatment with LPS or supernatant in vitro from mitogen-stimulated lymphocytes, while, at the same time, the tumoricidal activities of those macrophages can be kept or even enhanced following the same treatment. This phenomenon was then termed as "immune modulation" For the understanding of its mechanism, we are now undertaking signal transduction in modulated macrophages. Since mitogen-activated protein kinase (MAPK) is an integration point of different signal transduction pathways, its cascade and regulation of activation are being investigated extensively by the assay of electrophoresis mobility shift. Recent results suggested that interaction of ligand-receptor triggers protein tyrosine kinase(PTK) activation leading to Ras-GTP binding with Raf-1 to phosphorylate MAPK kinase (MAPKK), the specific activator of MAPK. It is reported that PKC-alpha can directly phosphorylate or activate Raf-1 in NIH3 T3 cells. Raf-1 (74 KDa), with an intrinsic serine (Ser)-threonine (The) kinase activity, becomes hyperphosphorylated after activation which can be followed by gel mobility shift test. It has also been shown that a variety of extracellular factors stimulate a pair of MAPK p44 and MAPK p42 of MAPK family members. A significant property of activation of ERK 1 and ERK 2 is the requirement for the phosphorylation of both Thr-183 and Tyr-185 (at TEY motif) within in its protein kinase subdomain VIII. More recently, two other MAPK subtypes, p38 MAPK (mammalian equivalents of HOG1 in yeast) and JNK MAPK have been discovered. The requirement for activation of p38 MAPK for both Thr-180 and Tyr-182 (at TGY motif) has been shown. p38 MAPK is important in certain transcriptional regulatory pathways, since it can phosphorylate the following transcriptional factors: 1) Elk at Ser 383/389 for binding with SRE motif; 2). ATF 2 at Ser 69/71, forming a complex with Myc for DNA binding at CRE motif; 3) Max at Ser-62 to combine DNA of E-Box motif. p38 MAPK can be activated by LPS, inflammatory cytokines, such as TNF and IL-1, osmolarity. To examine the possibility that whether activation of Raf-1 and ERK 1, ERK2 and p38 MAPK can be regulated directly or/and differently by PKC and PKA pathways, herbimycin A (Ki = 0.9 mumol/L), a potent PTK inhibitor (J. Immunol. 155:3944-4003, 1995) at 2 mumol/L concentration was utilized to block Ras/Raf-1/MAPK cascade. After pre-incubation of macrophages with herbimycin A for 30 min or 90 min, cells were treated with LPS (10 micrograms/ml) and PMA (100 nmol/L) for 15 min. No inhibition of phosphorylation of Raf-1, MAPK p44 and MAPK p42 in response to LPS and PMA was observed (Fig. 1 and 3). However, forskolin, a cAMP inducer for protein kinase A (PKA) activation, inhibited the phosphorylation of LPS- and PMA-stimulated Raf-1, MAPK p44 and MAPK p42 (Fig. 2 and 4). Similarly, in agreement with a very recent report from David, M et al in NIH, in which they indicated that forskolin (30 mumol/L) inhibited IFN-beta-stimulated ERK activity by U 266 cells (J. Biol. Chem. 271: 4585-4588 1996), we found that the levels of phosphorylations of Raf-1 and ERK1 and ERK2 were declined when forskolin (30 mumol/L) was added to macrophages for 20 min at 37 degrees C prior to the stimulation by LPS and PMA. Interestingly, under the same condition, forskolin (30 mumol/L) stimulated the phosphorylation of LPS- and PMA-triggered p38 MAPK of murine peritoneal suppressor macrophages, suggesting that activatio
作为宿主免疫细胞以杀灭病原体的单核细胞 - 巨噬细胞,在接触病毒、细菌、细胞因子以及化学物质后常常会被“激活”。然而,矛盾的是,尽管机制尚不清楚,但活微生物、微生物产物、肿瘤和自身免疫性疾病可诱导高度激活的巨噬细胞转变为抑制性巨噬细胞。我们之前的实验研究表明,体外使用脂多糖(LPS)或来自丝裂原刺激淋巴细胞的上清液处理,可阻止抑制性巨噬细胞对T、B和NK细胞的免疫抑制活性,同时,经过相同处理后,这些巨噬细胞的杀肿瘤活性可得以保持甚至增强。这种现象随后被称为“免疫调节”。为了解其机制,我们目前正在研究调节后巨噬细胞中的信号转导。由于丝裂原活化蛋白激酶(MAPK)是不同信号转导途径的整合点,通过电泳迁移率变动分析正在广泛研究其级联反应和激活调节。最近的结果表明,配体 - 受体相互作用触发蛋白酪氨酸激酶(PTK)激活,导致Ras - GTP与Raf - 1结合,使MAPK激酶(MAPKK)磷酸化,MAPKK是MAPK的特异性激活剂。据报道,PKC - α可在NIH3T3细胞中直接磷酸化或激活Raf - 1。具有内在丝氨酸(Ser) - 苏氨酸(Thr)激酶活性的Raf - 1(74 kDa),激活后会发生过度磷酸化,这可通过凝胶迁移率变动试验检测。还表明,多种细胞外因子可刺激MAPK家族成员中的一对MAPK p44和MAPK p42。ERK 1和ERK 2激活的一个重要特性是其蛋白激酶亚结构域VIII内的Thr - 183和Tyr - 185(TEY基序)都需要磷酸化。最近,又发现了另外两种MAPK亚型,p38 MAPK(酵母中HOG1的哺乳动物等同物)和JNK MAPK。已表明p38 MAPK激活需要Thr - 180和Tyr - 182(TGY基序)。p38 MAPK在某些转录调节途径中很重要,因为它可使以下转录因子磷酸化:1)Elk的Ser 383/389位点,以便与SRE基序结合;2)ATF 2的Ser 69/71位点,与Myc形成复合物以在CRE基序处结合DNA;3)Max的Ser - 62位点,以结合E - Box基序的DNA。p3八MAPK可被LPS、炎性细胞因子如TNF和IL - 1、渗透压激活。为了研究PKC和PKA途径是否能直接或/和不同地调节Raf - 1、ERK 1、ERK2和p38 MAPK的激活,使用浓度为2 μmol/L的强力PTK抑制剂赫伯霉素A(Ki = 0.9 μmol/L)(J. Immunol. 155:3944 - 4003, 1995)来阻断Ras/Raf - 1/MAPK级联反应。巨噬细胞与赫伯霉素A预孵育30分钟或90分钟后,用LPS(10 μg/ml)和佛波酯(PMA,100 nmol/L)处理15分钟。未观察到对LPS和PMA刺激的Raf - 1、MAPK p44和MAPK p42磷酸化的抑制作用(图1和3)。然而,用于激活蛋白激酶A(PKA)的cAMP诱导剂福斯高林抑制了LPS和PMA刺激的Raf - 1、MAPK p44和MAPK p42的磷酸化(图2和4)。同样,与David等人最近在NIH发表报告一致,他们指出福斯高林(30 μmol/L)抑制U 266细胞中IFN - β刺激的ERK活性(J. Biol. Chem. 271: 4585 - 4588 1996),我们发现,在LPS和PMA刺激前,将福斯高林(30 μmol/L)加入巨噬细胞中37℃孵育20分钟,Raf - 1、ERK1和ERK2的磷酸化水平下降。有趣的是,在相同条件下,福斯高林(30 μmol/L)刺激了小鼠腹腔抑制性巨噬细胞中LPS和PMA触发的p38 MAPK的磷酸化,表明激活……